Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-26-003293
Filing Date
2026-01-22
Accepted
2026-01-22 21:57:06
Documents
1
Period of Report
2025-12-23

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 6095
  Complete submission text file 0001493152-26-003293.txt   7622
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 (646) 427-2727
Indaptus Therapeutics, Inc. (Issuer) CIK: 0001857044 (see all company filings)

EIN.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 44 ZAYT SHEMEN ST. FLAT 4 EFRAT L3 9045544
Business Address
Ben-Tzvi Avraham (Reporting) CIK: 0001944721 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40652 | Film No.: 26553209